Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Оценка качества жизни и сексуальной функции женщин, использующих интравагинальную гормональную систему НоваРинг
Оценка качества жизни и сексуальной функции женщин, использующих интравагинальную гормональную систему НоваРинг
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Yuzpe AA. Oral contraception: trends over time. J Reprod Med 2002; 47: 967–73.
2. Caruso S, Agnello C, Intelisano G et al. Prospective study on sexual behavior of women using 30 ?g etinylestradiol and 3 mg drospirenon oral contraceptive. Contraception 2005; 72: 19–23.
3. Ware JE, Kosinski M. SF-36 Physical and mental health summary scales: a manual for users of version 1, 2nd edn. Linciln: Quality Metric Incorporated, 2001.
4. Basson R, Berman J, Burnet A et al. Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 2000; 163: 888–93.
5. Walton B, Trashawn T. Female sexual dysfunction. Curr Women's Health Reports 2003; 3: 319–26.
6. De Cherney AH. Hormone receptors and sexuality in the human female. J Women Health Gend Based Med 2000; S9: 9–13.
7. Berman JR. and Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405–16.
8. Graziottin A. Libido: the biologic scenario. Maturitas 2000; 34 (Suppl. 1): S9–S16.
9. Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauter-ine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999; 59: 277–86.
10. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001; 64: 51–8.
11. Caruso S, Agnello C, Intclisano G et al. Sexual behaviour of women taking low-dose oral contraceptive containing 15mg ethinylestradiol/60mg gestodene. Contraception 2004; 69: 237–40.
12. Guida M et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005; 20 (4): 1100–6.
13. Sabatini R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006; 74: 220–3.
14. Ромащенко О.В., Мельников С.Н. Состояние сексуального здоровья женщин на фоне применения гормональной контрацепции. Акуше. и гинекол. 2007; 7: 63–7.
2. Caruso S, Agnello C, Intelisano G et al. Prospective study on sexual behavior of women using 30 ?g etinylestradiol and 3 mg drospirenon oral contraceptive. Contraception 2005; 72: 19–23.
3. Ware JE, Kosinski M. SF-36 Physical and mental health summary scales: a manual for users of version 1, 2nd edn. Linciln: Quality Metric Incorporated, 2001.
4. Basson R, Berman J, Burnet A et al. Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 2000; 163: 888–93.
5. Walton B, Trashawn T. Female sexual dysfunction. Curr Women's Health Reports 2003; 3: 319–26.
6. De Cherney AH. Hormone receptors and sexuality in the human female. J Women Health Gend Based Med 2000; S9: 9–13.
7. Berman JR. and Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405–16.
8. Graziottin A. Libido: the biologic scenario. Maturitas 2000; 34 (Suppl. 1): S9–S16.
9. Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauter-ine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999; 59: 277–86.
10. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001; 64: 51–8.
11. Caruso S, Agnello C, Intclisano G et al. Sexual behaviour of women taking low-dose oral contraceptive containing 15mg ethinylestradiol/60mg gestodene. Contraception 2004; 69: 237–40.
12. Guida M et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005; 20 (4): 1100–6.
13. Sabatini R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006; 74: 220–3.
14. Ромащенко О.В., Мельников С.Н. Состояние сексуального здоровья женщин на фоне применения гормональной контрацепции. Акуше. и гинекол. 2007; 7: 63–7.
2. Caruso S, Agnello C, Intelisano G et al. Prospective study on sexual behavior of women using 30 ?g etinylestradiol and 3 mg drospirenon oral contraceptive. Contraception 2005; 72: 19–23.
3. Ware JE, Kosinski M. SF-36 Physical and mental health summary scales: a manual for users of version 1, 2nd edn. Linciln: Quality Metric Incorporated, 2001.
4. Basson R, Berman J, Burnet A et al. Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 2000; 163: 888–93.
5. Walton B, Trashawn T. Female sexual dysfunction. Curr Women's Health Reports 2003; 3: 319–26.
6. De Cherney AH. Hormone receptors and sexuality in the human female. J Women Health Gend Based Med 2000; S9: 9–13.
7. Berman JR. and Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405–16.
8. Graziottin A. Libido: the biologic scenario. Maturitas 2000; 34 (Suppl. 1): S9–S16.
9. Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauter-ine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999; 59: 277–86.
10. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001; 64: 51–8.
11. Caruso S, Agnello C, Intclisano G et al. Sexual behaviour of women taking low-dose oral contraceptive containing 15mg ethinylestradiol/60mg gestodene. Contraception 2004; 69: 237–40.
12. Guida M et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005; 20 (4): 1100–6.
13. Sabatini R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006; 74: 220–3.
14. Ромащенко О.В., Мельников С.Н. Состояние сексуального здоровья женщин на фоне применения гормональной контрацепции. Акуше. и гинекол. 2007; 7: 63–7.
________________________________________________
2. Caruso S, Agnello C, Intelisano G et al. Prospective study on sexual behavior of women using 30 ?g etinylestradiol and 3 mg drospirenon oral contraceptive. Contraception 2005; 72: 19–23.
3. Ware JE, Kosinski M. SF-36 Physical and mental health summary scales: a manual for users of version 1, 2nd edn. Linciln: Quality Metric Incorporated, 2001.
4. Basson R, Berman J, Burnet A et al. Definition and classification of female sexual dysfunction: second report of the international consensus development conference on female sexual dysfunction. J Urol 2000; 163: 888–93.
5. Walton B, Trashawn T. Female sexual dysfunction. Curr Women's Health Reports 2003; 3: 319–26.
6. De Cherney AH. Hormone receptors and sexuality in the human female. J Women Health Gend Based Med 2000; S9: 9–13.
7. Berman JR. and Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405–16.
8. Graziottin A. Libido: the biologic scenario. Maturitas 2000; 34 (Suppl. 1): S9–S16.
9. Oddens BJ. Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauter-ine devices, condoms, natural family planning, and sterilization among 1466 women. Contraception 1999; 59: 277–86.
10. Sanders SA, Graham CA, Bass JL, Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001; 64: 51–8.
11. Caruso S, Agnello C, Intclisano G et al. Sexual behaviour of women taking low-dose oral contraceptive containing 15mg ethinylestradiol/60mg gestodene. Contraception 2004; 69: 237–40.
12. Guida M et al. Effects of two types of hormonal contraception – oral versus intravaginal – on the sexual life of women and their partners. Hum Reprod 2005; 20 (4): 1100–6.
13. Sabatini R. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006; 74: 220–3.
14. Ромащенко О.В., Мельников С.Н. Состояние сексуального здоровья женщин на фоне применения гормональной контрацепции. Акуше. и гинекол. 2007; 7: 63–7.
Авторы
И.В.Кузнецова, Л.Н.Морозова, В.А.Коновалов
Кафедра акушерства и гинекологии №1 лечебного факультета ММА им. И.М.Сеченова
Кафедра акушерства и гинекологии №1 лечебного факультета ММА им. И.М.Сеченова
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.